RT Journal Article
SR Electronic
T1 Is this beginning or the end of COVID-19 battle in India? A data-driven mathematical model-based analysis of outbreak
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.27.20081422
DO 10.1101/2020.04.27.20081422
A1 Singh, Anupam
A1 Dey, Jhilik
A1 Bhardwaj, Shivam
YR 2020
UL http://medrxiv.org/content/early/2020/05/03/2020.04.27.20081422.abstract
AB The India has experienced early and harshest lockdown in response to the outbreak from 25th March 2020. However, an accurate estimation of progression of spread of the infection and level of preparedness to combat this disease are urgently needed. Using a data-based mathematical model, our study has made predictions on the number of cases that are expected to rise in India till 14th June 2020. The epidemiological data of daily cases have been utilized from 25th March (i.e., the first day of lockdown) to 23rd April 2020. In the study, we have stimulated two possible scenarios (optimistic and pessimistic) for the prediction. As per the optimistic approach of modeling, COVID-19 may end in the first week of June 2020 with a total of 77,900 infected cases including 2,442 fatalities. However, the results under the pessimistic scenario are bit scary. The results show that a total of 283,300 infected cases with 10,180 fatalities till 14th June. To win the battle, 10 weeks of complete lockdown is much needed at least in the infected states and the union territories of India. Alternatively, the isolation of clusters (hotspot regions) is required if India wants resume some essential activities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWorld Health Organization (WHO) https://www.who.int/ https://www.worldometers.info/coronavirus/